Biocon block deal today: Mylan may sell Rs 3,481 crore worth of shares in pharma major

Mylan to sell up to $363 million stake in India’s Biocon, term sheet shows

SINGAPORE, July 13 (Reuters) - Mylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, worth up to 34.81 billion Ind

Biocon Shares Rise After Mylan Exits Following Rs. 3,676-Crore Stake Sale

Biocon shares jump 6% on reports of ₹3,481-crore block deal; Mylan likely to exit after 17 years

Biocon to see block deals, as Viatris plans to exit

Floor price has been fixed as ₹378.50 a share, a discount of 7.9 per cent to current price

Emcure Pharma to Invest ₹231.87 Crore to Acquire 100% Control of Gennova Biopharmaceuticals

Emcure Pharmaceuticals moves from 87.95% to 100% ownership of Gennova Biopharmaceuticals for ₹231.87 crore, simplifying its corporate struct

Bone Biologics prices $9.0M offering at $1.42 per share.

See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F